AscentX Medical, Inc. has raised $1.7M in total funding. The most recent round was Seed.
AscentX Medical, Inc. is headquartered in San Diego, CA.
Aging patients and clinical populations experience declines in tissue function and quality of life that have traditionally been accepted as an inevitable part of aging.
AscentX Medical develops injectable regenerative therapy using autologous tissue engineering (injectable microspheres) that harnesses the body's own regenerative capabilities to restore tissue function.
The company cites '20 years of research and development' behind its autologous, injectable-microsphere tissue-engineering technology, which it describes as producing biocompatible, long-lasting solutions that integrate seamlessly with the body; it also notes plans for a cGMP contract manufacturing (fill-and-finish) service line.
AscentX Medical was founded by Dr. Stefan Lemperle and has raised over $10 million, including a grant from the European Union's Horizon 2020 program.
Free to use in articles, research, and reference works. Stable URL, will not change. Data on this page last updated August 26, 2026.